IRTC - NASDAQ
iRhythm Technologies, Inc.
$104.56
+1.5%iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
At a Glance
Live Snapshotirtc
Shares Outstanding
Last Annual Value
32.00M
3-Year CAGR
2%
5-Year CAGR
3%
10-Year CAGR
8%
iRhythm Technologies, Inc. Competitors Analysis of shares-outstanding
| Company | shares-outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
iRhythm Technologies, Inc. NASDAQ:IRTC | 32.00M | 1.6% | 1.8% | 19.7% | |
 Bruker Corporation NASDAQ:BRKR | 151.80M | 1.0% | -0.1% | -0.7% | |
 Chemed Corporation NYSE:CHE | 14.40M | -1.8% | -2.0% | -1.5% | |
 Vaxcyte, Inc. NASDAQ:PCVX | 136.09M | 11.9% | 21.3% | N/A | |
219.77M | 8.7% | 5.1% | N/A | ||
 Glaukos Corporation NYSE:GKOS | 57.19M | 5.7% | 4.3% | 4.6% | |
 Teleflex Incorporated NYSE:TFX | 44.72M | -1.9% | -1.2% | -0.6% | |
 Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR | 133.76M | 7.8% | 5.2% | 8.2% | |
 RadNet, Inc. NASDAQ:RDNT | 75.19M | 5.2% | 7.1% | 4.9% |
iRhythm Technologies, Inc. Fair Value Envelope
Related Guides
Continue your IRTC research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.